Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001908938 | SCV002174262 | uncertain significance | Autosomal recessive polycystic kidney disease | 2021-09-17 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with isoleucine at codon 2584 of the PKHD1 protein (p.Val2584Ile). The valine residue is highly conserved and there is a small physicochemical difference between valine and isoleucine. This variant is present in population databases (rs748895723, ExAC 0.009%). This variant has not been reported in the literature in individuals with PKHD1-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PKHD1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002482797 | SCV002788901 | uncertain significance | Polycystic kidney disease 4 | 2022-03-16 | criteria provided, single submitter | clinical testing |